Turns out there is a higher prevalence of cross-reactive antibodies against Severe Acute Respiratory Syndrome (SARS-CoV-2) in the blood samples collected from sub-Saharan African populations.
Africans have prior exposure to other human coronaviruses and have antibodies against them.
Read More: